Science

Feds Probe ADHD Pill Prescriber That Advertises on TikTok

UNDER THE MICROSCOPE

The telehealth startup was subpoenaed amid claims it overprescribes without proper patient evaluations.

Attention_deficit_hyperactivity_disorder_-_Attention_deficit_hyperactivity_disorder_-_Reduced_brain_volume_on_the_left_side_from_ADHD_fmvyxo
Scientificanimations.com

Cerebral, the telehealth company behind ubiquitous TikTok ads offering quick pharmaceutical relief for ADHD, confirmed Saturday that it’s under investigation by federal prosecutors. The news comes weeks after the Wall Street Journal reported that some nurse practitioners felt the company was pressuring them to prescribe stimulants without proper patient evaluations—and that some pharmacies were rejecting prescriptions from Cerebral. The company, which has denied the allegations, said it will comply with a subpoena. “The safe medical care of our patients is our highest priority,” it said.

Read it at The Wall Street Journal

Got a tip? Send it to The Daily Beast here.